Sanofi recalls some batches of painkiller Combiflam in India

Sanofi recalls some batches of painkiller Combiflam in India

Sanofi is recalling some batches of its painkiller Combiflam in India after the country`s drugs regulator found the lots were substandard, the French drugmaker`s local unit said on Thursday.

Indian firms get FDA approval for 110 generic drugs

Drugmakers from India, the biggest overseas source of medicines sold in the US, have got more than 100 generic drug approvals from the American health regulator FDA this year so far.

Indian pharma draws more scrutiny as US exports rise

India's drugmakers, battered by a rash of US regulatory rebukes including a record fine for Ranbaxy Laboratories, face closer FDA scrutiny as the agency ramps up its presence in the country.

US to hike fees for generic drugmakers; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October.